[Ip-health] EB140: WHO publishes draft decision on terms of reference for overall programme review of the GSPOA (31 Jan 2017)

Thiru Balasubramaniam thiru at keionline.org
Mon Jan 30 23:49:44 PST 2017


http://keionline.org/node/2719
EB140: WHO publishes draft decision on terms of reference for overall
programme review of the GSPOA (31 Jan 2017)
Submitted by thiru <http://keionline.org/user/6> on 31. January 2017 -

On 31 January 2017 the WHO Secretariat published the "Draft decision
resulting from informal consultations" on the Overall programme review of
the global strategy and plan of action on public health, innovation and
intellectual property (EB140/CONF./7 Rev.1). This can be found here
<http://apps.who.int/gb/ebwha/pdf_files/EB140/B140_CONF7Rev1-en.pdf>:
http://apps.who.int/gb/ebwha/pdf_files/EB140/B140_CONF7Rev1-en.pdf

The chapeau to this decision notes:

The Executive Board decided to approve the terms of reference of the
overall programme review of the global strategy and plan of action on
public health, innovation and intellectual property, set out in the Annex
to this decision, and also to request the Secretariat to develop an
indication of funding requirements and possible sources of the
implementation costs of the recommendations of the programme review, and
present these to the Seventy-first World Health Assembly in 2018 through
the Executive Board at its 142nd session.

The proposed decision is contained below. The 140th session of the
Executive Board (EB) will examine this draft decision during today's
morning session which commences at 9:00.

ANNEX
TERMS OF REFERENCE OF THE OVERALL PROGRAMME REVIEW

1. As directed in resolution WHA68.18 (2015), the overall programme review,
as distinct from the evaluation, will be a more policy-oriented,
forward-looking exercise. The expert review panel’s conclusions should
identify areas of convergence, in line with the 10 principles of the global
strategy and plan of action on public health, innovation and intellectual
property (contained in the annex to resolution WHA61.21 (2008)). Guided by
the report of the comprehensive evaluation and, where appropriate, taking
into account other evidence and involving relevant stakeholders, including
public sector entities and all categories of non-State actors in line with
FENSA involved in biomedical research and development, the programme review
will:

(a) assess the continued relevance of the aim and objectives and the eight
elements of the global strategy and plan of action;

(b) consider the evaluation of the implementation of the global strategy
and plan of action so far and its key barriers;

(c) review achievements, good practices, success factors, opportunities,
gaps, weaknesses, unsuccessful efforts, remaining challenges, and value for
money;

(d) invite, over the course of the evaluation, appropriate input and
comment from WIPO, WTO, and UNCTAD and other relevant intergovernmental
organizations;

(e) recommend a way forward, including details of what elements or actions
should be added, enhanced or concluded in the next stage of implementation
of the global strategy and plan of action on public health, innovation and
intellectual property, until 2022;

(f) submit a final report to the Health Assembly, including the assessment
of the global strategy and plan of action and recommendations on the way
forward.

2. The final report of the overall programme review of the global strategy
and plan of action on public health, innovation and intellectual property,
focusing on its achievements, remaining challenges and recommendations on
the way forward will be presented to the Seventy-first World Health
Assembly in 2018 through the Executive Board at its 142nd session.



More information about the Ip-health mailing list